Published on
June 22, 2020
- 13:00 GMT
SOTIO Presents New Data Showing Strong Anti-tumor Effect of IL-15 Superagonist SO-C101 in Mice at 2020 AACR Virtual Annual Meeting ...
PRAGUE, June 22, 2020 (GLOBE NEWSWIRE) -- SOTIO and Cytune Pharma from the PPF Group, today presented new preclinical data highlighting the therapeutic potential of SO-C101, an IL-15 superagonist, as a monotherapy and in combination with PD-1 inhibitors in …
Distribution channels:
Media, Advertising & PR, Technology
...
